Zepbound is FDA-approved for adults with obesity and obstructive sleep apnea. If you have sleep apnea — or may have it without knowing — Sleep Reset can help you explore whether GLP-1 treatment may be appropriate and what coverage options may be available.
During your visit, a licensed clinician will discuss eligibility, treatment options, insurance considerations, and whether sleep testing may be helpful.
Obstructive sleep apnea is common, underdiagnosed, and closely tied to weight. For eligible patients, identifying OSA may create a clearer path to GLP-1 treatment through insurance.
During your visit, we’ll review your weight history, sleep apnea risk, insurance situation, and cash-pay alternatives so we can help identify the most affordable GLP path available.
This is the strongest insurance-supported path. If your plan covers GLP treatment for obstructive sleep apnea, your out-of-pocket medication cost may be limited to your normal pharmacy benefit or visit copay.
Insurance may still be possible depending on your plan and clinical profile. This average includes people who may be able to access GLP treatment through insurance, as well as people who may need to use cash-pay options depending on their plan, diagnosis, and medication choice.
Even if you are not eligible for insurance coverage, we work directly with manufacturers to help you access their lowest available price when treatment is clinically appropriate.
Coverage is not guaranteed and depends on your plan, diagnosis, medication, and insurer policies. GLP-1 medications are prescribed only if clinically appropriate.
You do not need to choose between insurance, cash pay, or sleep testing before you know what is clinically relevant. The visit is where your options are reviewed.
The first step is a clinician visit. From there, we help determine whether GLP-1 treatment, insurance documentation, or sleep testing should come next.
A licensed clinician will help you understand eligibility, treatment options, and your most realistic next step.
Schedule a VisitGLP-1s are treatments with important risks, including a warning for thyroid tumors, risk of pancreatitis, and other serious side effects. They are not right for everyone. Orders are issued at the sole discretion of the treating clinician. See full safety information ↗